Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness.
Programmed Self-Assembly of Hierarchical Nanostructures through Protein-Nanoparticle Coengineering.
DETECTION OF MICROVASCULAR CHANGES IN EYES OF PATIENTS WITH DIABETES BUT NOT CLINICAL DIABETIC RETINOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
The initiator caspase Dronc is subject of enhanced autophagy upon proteasome impairment in Drosophila.
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
See All 28 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
Braun J, Kay J. The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2017 Mar; 16(3):289-302.
View in:
PubMed
subject areas
Antirheumatic Agents
Arthritis, Rheumatoid
Biosimilar Pharmaceuticals
Drug Design
Health Services Accessibility
Humans
Rituximab
Tumor Necrosis Factor-alpha
authors with profiles
Jonathan Kay MD